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The gastrointestinal tract is a major site of host 
invasion by pathogenic organisms. Indeed, 
even during periods of health, the gut lumen is 
the site of a large population of bacteria, which 
under normal conditions contribute to the via-
bility of the host (1, 2). However, this balanced 
state of coexistence is not autonomous but ac-
tively maintained by local protective mecha-
nisms such as defensins (3) and ongoing adaptive 
immune responses that help ensure that the 
commensal bacteria remain resident on the lu-
menal side of the gut lining (4). Defects in these 
protective responses, for example, sIgA defi  -
ciency, can result in breach of this barrier, with 
potential consequences ranging from septice-
mia to infl  ammatory bowel disease (5).
Both T-dependent and T-independent B 
cell antibody production contribute to ongo-
ing anti-commensal immunity as well as to 
acute responses against pathogenic organisms. 
Antigen associated with DCs plays a key role 
not only in the well-recognized activation of 
T cells that can provide help for B cells, but 
also in the direct presentation of antigen to B 
cells (5–9). Thus, the mechanisms by which 
gut-localized DCs acquire antigenic informa-
tion are of signifi  cance in both the maintenance 
of homeostasis and in the development of pro-
tective immunity to pathogens.
Specialized cells (M cells) situated in the 
dome region of Peyer’s patches are a major 
route for the transfer of antigen, including in-
tact bacteria and viruses, from the gut lumen to 
underlying DCs (10, 11). Recent studies sug-
gest that M cells also exist in villi where they 
may contribute to the transfer of organisms 
from bowel lumen to lamina propria DCs 
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(12, 13). Under nonpathogenic conditions, these antigen-laden 
DCs can interact with associated T and B lymphocytes to gen-
erate a noninfl  ammatory immune response biased through lo-
cal signals such as TGFβ (14, 15) and in humans, TSLP (16). 
However, during noncommensal bacterial invasion, signals 
provided directly or indirectly by these organisms can alter 
the diff  erentiation of freshly recruited DCs and deviate the 
immune response to a more infl  ammatory character (16).
In the past few years, another mode of antigen uptake 
within the gastrointestinal tract has been reported. In vitro 
studies using a model epithelial cell line fi  rst revealed the ca-
pacity of DCs on the basolateral (ablumenal) side of the epi-
thelium to extend processes across the tight junctions between 
these cells and capture bacteria from the apical (lumenal) side 
(17, 18). Remarkably, this extension occurred without com-
promising the integrity of the epithelial barrier, apparently 
as a result of the creation of a tight junction-like structure 
between the dendrites and the contiguous epithelial cells. 
Immunohistochemical studies with gut tissue provided initial 
limited evidence that such DC extensions existed in vivo, a 
result confi  rmed and extended by more recent high resolu-
tion static imaging studies (13, 19). These latter papers used 
fractalkine receptor (CX3CR1)-driven expression of en-
hanced GFP (EGFP) to visualize the gut DC population and 
suggested that CX3CL1 may play a role in guiding extension 
of this DC subset across the epithelium. These experiments 
also showed that the EGFP-expressing DCs acquired micro-
organisms from the gut lumen when fractalkine signaling 
was present, although the study by Vallon-Eberhard et al. 
(13) did not fi  nd the extensions to be required for such trans-
epithelial transport.
In both of these previous analyses, exposure of the small 
bowel lumenal surface to bacterial or fungal products was 
shown to increase the extent of trans-epithelial DC exten-
sion, but no information was obtained on the mechanism of 
this induced response. Likewise, the question of whether the 
steady-state level of DC trans-epithelial extension is a consti-
tutive activity of the DCs or sustained by stimuli from com-
mensal fl  ora has not been addressed, although the addition 
of commensal organisms to the gut lumen under defi  ned 
conditions has been shown to increase the number of such 
extensions (19). Here, we explore this issue of regulated 
trans-epithelial extension of processes by lamina propria DCs 
using dynamic explant and intravital imaging methods to vi-
sualize these events under a variety of experimental  conditions. 
We fi  nd that these DC-derived processes, which often have 
an unusual spherical (“balloon body”) shape and whose 
  frequency varies along the small bowel length, are generated 
in large measure in response to MyD88-dependent signaling 
by a subset of Toll-like receptors (TLRs) expressed by non-
hematopoietic (epithelial) cells. Our fi  ndings strongly sup-
port the previously proposed model of gastrointestinal lumen 
sampling by DCs and provide new insight into the location 
and structural characteristics of the trans-epithelial extensions 
as well as initial characterization of the signals inciting this 
sampling of the gut lumenal fl  ora.
RESULTS
Differences in the frequency of lamina propria 
DC extensions along the length of individual villi 
and of the small bowel in normal mice
Two high resolution microscopic studies have documented 
the presence of abundant trans-epithelial DC extensions in 
the small bowel of mice on the C57BL/6 background (13, 
19). To determine the optimal site(s) for dynamic imaging of 
such extensions, we fi  rst conducted a similar static imaging 
analysis using explants from distinct subregions of the small 
bowel. Previous studies examined DCs marked by EGFP ex-
pression under the control of the CX3CR1 gene regulatory 
region. Here, we studied small bowel segments from mice 
whose DCs expressed a fl  uorescent MHC class II molecule in 
which the Aβb chain is covalently linked to EGFP as a con-
sequence of gene targeting (MHC CII-EGFP; reference 20) 
or from mice whose DCs expressed cytoplasmic EGFP under 
control of the CD11c promoter-enhancer region (CD11c-
EGFP; reference 21). In the case of the tissues from the Aβb 
gene-targeted animals, the identity of the fl  uorescent cells as 
DCs was confi  rmed using RAG-2−/− animals that lack B cells 
and by FACS analysis of dissociated tissue (Fig. S1, available 
at http://www.jem.org/cgi/content/full/jem.20061884/DC1).
A representative three-dimensional reconstruction of a 
small bowel imaging dataset is shown in Fig. 1 A and Video 
S1, which is available at http://www.jem.org/cgi/content/
full/jem.20061884/DC1. In agreement with previous fi  nd-
ings, each villus in this image from the ileum 30 cm distal to 
the stomach had several DC extensions visible on the lume-
nal side of the epithelium. Two features were notable in these 
imaging data. First, the extensions were more frequent in the 
apical region of the villi and rarer near the basal regions close 
to crypts (Fig. 1 B and Video S2), although no diff  erence 
in DC numbers was detected along the length of the villi. 
Second, the extensions had an unusual shape, most often being 
nearly spherical rather than fi  nger-like (Fig. 1, A and C), giv-
ing rise to what we call balloon bodies (BBs). This shape was 
seen using several distinct surgical preparations of the bowel 
segment and with various media bathing the tissue during 
imaging (unpublished data), but because the majority of the 
residual bowel contents and mucus must be removed for suc-
cessful imaging in all cases, we cannot be certain that this 
shape is adopted by DC extensions under truly physiological 
conditions (see Discussion). Globular structures were also 
noted in at least a subset of the trans-epithelial extensions 
of CX3CR1-EGFP cells imaged by others (13, 19). Similar 
numbers, distribution, and shapes of DC trans-epithelial ex-
tensions were seen using CD11c-EGFP or MHC CII-EGFP 
mice. The common fi  ndings using both of these reporter ani-
mals make it unlikely that the extensions originate from mu-
cosal macrophages that have been reported to be CD11c+ (22).
When the frequency of such trans-epithelial DC exten-
sions was measured along the length of the small bowel, clear 
regional diff  erences were observed (Fig. 2 A). The extensions 
were present in substantial number from the jejunum through 
most of the ileum, with a slightly greater frequency in the JEM VOL. 203, December 25, 2006  2843
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proximal portion of the latter small bowel segment. How-
ever, villi in the terminal 5 cm of the ileum near the cecal 
  region had a very low number of DC extensions in unma-
nipulated healthy animals. These observations diff  er  from 
those reported previously using mice expressing EGFP under 
the control of the CX3CR1 gene regulatory region (13, 19), 
in which the terminal ileum was found to have the highest 
density of visualized extensions. Both these earlier reports 
and ours involve mice on the same genetic background 
(C57BL/6), making this an unlikely source of the diff  erence. 
The major distinction between the studies is the method 
for detecting DCs involving EGFP expression by only the 
CX3CR1+ subset in the case of the previous reports and a 
broader analysis involving labeling of all CD11c+ or MHC 
class II+ DCs in the present case. The following sections pro-
vide evidence that analysis of DC subsets diff  erentially marked 
by the various reporter constructs may account for these con-
trasting observations.
Small bowel bacterial content affects the frequency 
of trans-epithelial DC extension
The variation in the frequency of DC extension both along a 
villus and the length of the small bowel could refl  ect either 
intrinsic properties of the tissue or the impact of exogenous 
Figure 1.  DCs extend through the apical epithelium of villi. 
(A) Static two-photon microscopy image of the villi in the peri-cecal region 
of a CD11c-EGFP mouse given noninvasive Salmonella orally 3 h before 
imaging (top). The image is a three-dimensional reconstruction of 65 serial 
optical sections (1.5 μm/z-section) comprising a total depth of 97.5 μm. 
Extensions of DCs (green) into the intestinal lumen can be observed. The 
surface of the villi was outlined by SNARF-1 staining of the epithelial 
cells (red). Bar, 25 μm. Boxed region in the top panel is shown in a higher 
magnifi  cation in the bottom panel to better illustrate how DC extensions 
(green) protrude through the intestinal epithelium (red) into the luminal 
cavity. The arrows indicate examples of spherical DC extensions into the 
intestinal lumen (also see Video S1). (B) A representative static image of 
an ileal villus from an MHC CII-EGFP mouse stained with SNARF-1 to 
highlight the epithelial cells (red) shows the preferential location of DC 
extensions (green) near the apical region of the villus (white arrows). 
The villus was arbitrarily subdivided in 10 equal compartments from the 
bottom to the apical region (z = 0 to z = 100), and the average number of 
DC extensions in each compartment is displayed in the histogram. Values 
are expressed as the number of DC extensions per villus in the indicated 
section (mean ± SE). The top regions (z = 70–100; open bars) show a 
signifi  cant difference in the number of DC extensions as compared with 
the middle and lower parts (z = 40–70; striped bars) of the villi. Also see 
Video S 2. (C) A single optical z-slice of a villus from the ileum of an MHC 
CII-EGFP mouse. Epithelial cells are stained with SNARF-1 (red), and the 
cell nuclei are stained with Hoechst 33342 (blue). The higher magnifi  ca-
tion in the bottom panel demonstrates a DC extending an MHC CII+ 
(green) dendrite through the epithelium. Once reaching the intestinal 
lumen, the DC dendrite assumes the characteristic shape of a sphere 
(white arrow).2844  TLR CONTROL OF TRANS-EPITHELIAL DENDRITIC CELL EXTENSION | Chieppa et al.
stimuli that actively induce the extension response. A likely 
source of such exogenous stimuli is the commensal bacteria 
of the gut, a possibility we examined by treating mice with 
broad-spectrum antibiotics for 5 d to reduce the bacterial 
load and then analyzing the distribution and number of DC 
extensions. This treatment resulted in a signifi  cant decrease in 
the frequency of DC extensions in the proximal regions of 
the small bowel where they were the most numerous in nor-
mal animals (Fig. 2 B). DC protrusions were not completely 
abrogated, possibly due to the residual bacterial population 
remaining after antibiotic treatment. In agreement with pre-
vious data implicating microbial stimuli in induction of DC 
extensions, an additional bacterial load consisting of live 
Salmonella administered by gavage led to the appearance of a 
substantial number of extensions in the peri-cecal region in 
which such DC processes were typically rare in normal mice 
(Fig. 2 A). The induction of BBs can be detected 3 h after 
bacteria gavage. The process reaches a peak a few hours later 
(Fig. 3), with the number of extensions then remaining 
constant for up to 24 h (not depicted). No signifi  cant diff  er-
ences in the induction of DC extensions were observed 
using invasive versus noninvasive strains of Salmonella in such 
experiments (Fig. 3). Collectively, these data suggest that 
many, if not most, DC trans-epithelial extensions arise as an 
active response to microbial products. As for the extensions 
seen in animals not treated with Salmonella, the extensions 
in infected mice were most frequent near the tip of the villi 
(not depicted).
MyD88-dependent signaling by diverse epithelial TLRs 
induces DC extension
Our observations and those reported previously suggested 
that pathogen-associated molecular pattern (PAMP) recogni-
tion might be directly or indirectly responsible for triggering 
DCs to extend processes across the epithelial cell layer. Both 
epithelial cells and DCs express TLRs that could mediate sig-
naling in response to such material (16, 23, 24). Oral admin-
istration of peptidoglycan (PG), LPS, or CpGs (TLR2, 
TLR4, and TLR9 ligands, respectively) was suffi   cient to in-
duce DC protrusion in the terminal ileum, whereas the TLR3 
ligand polyinosine-polycytidylic acid (poly(I:C); reference 
25) and the TLR5 ligand fl  agellin (26) failed to do so (Fig. 4). 
These fi  ndings are in accord with evidence that TLR3 is not 
expressed on intestinal epithelial cells and that TLR5 is ex-
pressed at a very low level in the terminal part of the small 
intestine and may be predominantly present in lamina propria 
DCs (27, 28).
To study further the role of TLR signaling in triggering 
DC lumenal protrusions, we constructed three diff  erent bone 
marrow chimeras. The fi  rst was prepared using donor bone 
marrow from mice expressing CD11c-EGFP and recipients 
that were either wild-type or defective in TLR4 expression 
(29, 30). The second and the third chimeras were constructed 
using donor bone marrow from mice expressing MHC CII-
EGFP (20) and recipients that were either defective in TLR2 
or MyD88 expression (31, 32). After reconstitution, small 
bowel tissue from these mice was examined for DC exten-
sions in the absence or presence of added TLR ligands.
Figure 2.  Inducible DC extensions in the terminal ileum. Explanted 
small intestinal segments from untreated (open bars) or noninvasive 
Salmonella-treated (fi  lled bars) mice were analyzed by two-photon micros-
copy for the presence of trans-epithelial DC extensions. (A) The number 
of DC extensions was determined by inspection of each z-slice in image 
stacks collected in multiple sites within the indicated subregions of the 
small bowel. The data are presented as the average number of extensions 
± SE/villus. The data show representative results from one of three inde-
pendent experiments, each involving fi  ve random acquisitions per intesti-
nal region with three to eight villi visualized per acquisition. (B) Average 
numbers of DC extensions in the proximal ileum of untreated (open bar) 
or antibiotic-treated (striped bar) mice were analyzed as in A. Results are 
representative of three separate experiments.
Figure 3.  Invasive and noninvasive Salmonella induce a similar 
number of DC extensions. MHC CII-EGFP mice were treated orally with 
noninvasive (NIS; open bars) or invasive (IS; fi  lled bars) Salmonella for 1, 3, 
or 5 h. The small intestine peri-cecal region was explanted and imaged, and 
the average number of DC extensions was calculated as described in Fig. 2. 
Data represent the average number of extensions ± SE/villus from >50 villi.JEM VOL. 203, December 25, 2006  2845
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Hosts with and without epithelial cell expression of either 
TLR2 or TLR4 had similar numbers of DC extensions in the 
proximal bowel regions that normally contained such pro-
cesses. However, hosts lacking epithelial TLR4 did not show 
the induced appearance of such extensions in the peri-cecal 
region after administration of the TLR4 ligand LPS, even 
though the DCs in these animals expressed the receptor for 
LPS, whereas there was a signifi  cant increase in the number 
of such processes in control chimeras expressing TLR4 in 
nonhematopoietic cells (Fig. 4). Similarly, hosts lacking epi-
thelial TLR2 did not show DC extensions in response to the 
TLR2 ligand PG in this segment of the small bowel, whereas 
control chimeras did (Fig. 4). Trans-epithelial projections from 
the DCs could be induced in both of these chimeras if nonin-
vasive Salmonella organisms were administered, consistent with 
the diversity of potential TLR ligands produced by these bac-
teria and the ability of each of several TLR ligands to induce 
extensions when added individually (Fig. 4). Hosts lacking epi-
thelial expression of MyD88 did not show DC extensions in 
response to Salmonella and had markedly fewer extensions in 
the absence of TLR ligand instillation or Salmonella infection 
(Fig. 4). These latter results suggest a possible minor role for 
the MyD88-independent pathway of TLR signaling (33, 34) 
or a very low baseline level of protrusion unrelated to TLR 
stimuli (Fig. 3). Overall, these results indicate that most DC 
extensions across the small bowel epithelium occur in response 
to MyD88-dependent TLR signaling via receptors expressed 
by the epithelial cells themselves and that distinct TLRs can 
independently mediate this eff  ect upon ligand exposure.
Given the diff  erences in distribution of DC extensions in 
previous studies of cells expressing EGFP under control of 
the CX3CR1 locus versus the present analyses using CD11c 
or MHC CII–regulated EGFP expression, we used this in-
formation on actively induced DC extension to probe the 
relationship between CX3CR1, CX3CL1, and Salmonella-
induced DC extensions. Previous work described CX3CR1-
defi  cient DCs as being unable to extend processes into the 
gut lumen, leading to the conclusion that CX3CL1-induced 
signaling was a necessary factor in this phenomenon (13, 19). 
Using CX3CR1-EGFP homozygous mice defi  cient  in 
CX3CR1 expression, we confi  rmed that there is no increase 
in the number of DCs sending projections into the terminal 
ileum upon Salmonella infection. Surprisingly, in the proxi-
mal ileum of these same mice, we detected a signifi  cant in-
crease in DC projections (Fig. S2, available at http://www.
jem.org/cgi/content/full/jem.20061884/DC1). These re-
sults indicate that DCs lacking CX3CR1 are nonetheless 
able to respond to signals evoked by infl  ammatory stimuli by 
sending processes across the bowel epithelium.
To study the role of CX3CL1 in DC protrusions, we 
used quantitative PCR to measure CX3CL1 mRNA levels 
in the small bowel tissue of mice given noninvasive Salmo-
nella orally. No signifi  cant diff  erences in the level of CX3CL1 
mRNA were detected in the terminal ileum of infected as 
compared with uninfected mice, even though exposure to 
this bacterium evoked a strong DC extension response in this 
region of the small bowel as assessed using CD11C-EGFP or 
MHC CII-EGFP animals (Fig. S3, available at http://www.
jem.org/cgi/content/full/jem.20061884/DC1, and Figs. 3 
and 4). Given our fi  nding that CX3CL1 mRNA levels did 
not change upon Salmonella infection, we examined whether 
any other chemokines known to aff  ect DC behavior in the 
gut might be produced in a MyD88-dependent fashion in 
response to this stimulus. CCL20 is known to be produced 
by the intestinal epithelium in response to TLR stimuli (35). 
We therefore measured the level of mRNA for this chemo-
kine in response to noninvasive Salmonella infection. An 18-
fold increase in the level of CCL20 mRNA was measured in 
the terminal ileum of wild-type infected mice as compared 
with untreated mice (Fig. S3). MyD88-defi  cient mice did not 
show this increase in chemokine mRNA, in accord with the 
preceding data showing that such animals largely lacked trans-
epithelial DC extensions and that in these animals extensions 
could not be induced by TLR ligands or Salmonella.
Collectively, these data suggest that CX3CL1 is not di-
rectly involved in actively induced DC protrusion across the 
intestinal epithelium in the terminal ileum and that DCs 
marked using CX3CR1-EGFP expression are either distinct 
Figure 4.  Role of epithelial TLRs and MyD88-dependent signaling 
in the induction of DC extensions. (A) Extensions of DCs across the 
small bowel epithelium were measured in MHC CII-EGFP animals as 
described in Fig. 2 either without treatment or after PG, poly(I:C), LPS, 
fl  agellin, or CpGs administration. (B) TLR4-, TLR2-, or MyD88-defi  cient 
recipient mice were irradiated and reconstituted with bone marrow 
cells from CD11c-EGFP (for TLR4-defi  cient recipients) or MHC CII-EGFP 
(for TLR2- and MyD88-defi  cient recipients) mice, respectively, to create 
CD11c-EGFP/TLR4−/−, MHC CII-EGFP/TLR2−/−, and MHC CII-EGFP/MyD88−/− 
bone marrow chimeras. The extensions of DCs across the small bowel 
epithelium were measured in these chimeric animals as described in 
Fig. 2 either without treatment or after noninvasive Salmonella gavage, 
as indicated. Data are represented as the average number of extensions 
± SE/villus from two independent experiments for each chimera type.2846  TLR CONTROL OF TRANS-EPITHELIAL DENDRITIC CELL EXTENSION | Chieppa et al.
from or a subpopulation of those marked by CD11c-EGFP 
or MHC CII-EGFP labeling, potentially accounting for the 
diff   erent distribution of trans-epithelial extensions seen in 
previous studies as compared with the present investigation.
Dynamic visualization of the DC extension process
The demonstration that DC extensions could be actively in-
duced by TLR signaling provided a method for capturing the 
process using four-dimensional (space and time) imaging 
methods. Explants from the peri-cecal small bowel region of 
animals expressing MHC CII-EGFP were imaged for up to 
4 h using two-photon microscopy, using the red fl  uorescent 
dye carboxylic acid acetate succinimidyl ester (SNARF)-1 to 
counterstain the epithelial cells. Within 3 h of exposure of 
these explants to LPS or bacteria, the apical regions of villi in 
the peri-cecal region began to show the active emergence of 
DC processes across the epithelial layer. Although these were 
occasionally fi  nger-like in appearance (Fig. 5 A and Video S3, 
which is available at http://www.jem.org/cgi/content/full/
jem.20061884/DC1), balloon-shaped structures dominated 
(Fig. 5 B and Videos S4 and S5). Once extended across the 
epithelium, the DC processes typically remained present for 
10–40 min before being withdrawn.
In vitro data indicated that DC extension across a recon-
stituted epithelial cell layer occurred without disruption of 
the tight junction (17, 18). To examine if this was the case 
using normal tissue, fl  uorescent dextran was added to the me-
dium bathing the explants. No accumulation of the exoge-
nous dextran was seen in the lamina propria or in the DCs 
themselves (Fig. 6 and Video S5). This is consistent with the 
maintenance of the epithelial junctions and with limited mac-
ropinocytosis or micropinocytosis by the DC extensions.
Bacterial interaction with DC extensions
Previous work using in vitro models, tissue explants, and 
closed loop preparations demonstrated that DCs can capture 
Figure 5.  Characteristics of DC trans-epithelial extensions. 
(A) MHC CII-EGFP mice were deprived of food for 4 h before oral Salmonella 
administration. The terminal ileum was then imaged by intravital two-
photon microscopy. The nuclei of all the cells were labeled with Hoechst 
33342 (blue), and the epithelium was stained with SNARF (red). Two dif-
ferent DCs can be seen extending dendritic processes into the intestinal 
lumen. In this example, both BB (#) and fi  nger-like (*) dendritic extensions 
can be seen in the same villus (also see Video S3). (B) MHC CII-EGFP 
mice were deprived of food for 4 h before oral noninvasive Salmonella 
administration. The terminal ileal epithelium was then labeled with SNARF-1 
(red) and imaged by two-photon microscopy. Sequential images from a 
time series are shown at high magnifi  cations and reveal a dendrite reach-
ing the luminal side and acquiring the BB shape. The protrusion is almost 
completely retracted after 22 min (see Video S4).JEM VOL. 203, December 25, 2006  2847
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bacteria across an epithelial barrier (13, 17, 19). We con-
fi  rmed these data using the previously described experimental 
model (17) and static imaging (unpublished data), and then 
conducted four-dimensional imaging in an attempt to char-
acterize this process dynamically. Using both explant and in-
travital methods, it was possible to obtain rare images of DC 
BBs interacting with noninvasive Salmonella (36, 37) in the 
lumenal space (Fig. 7 A and Video S6, which is available at 
http://www.jem.org/cgi/content/full/jem.20061884/DC1) 
and BBs with a captured red Salmonella inside (Fig. 7 B and 
Video S7). However, the infrequent nature of these events 
(the total accumulation of noninvasive Salmonella after gavage 
was never >10–20 organisms per villus per 24 h), as well as 
rapid bleaching of the captured organisms, precluded direct 
visualization of binding and withdrawal of bacteria-containing 
processes into the lamina propria.
DISCUSSION
In this paper, we have used dynamic explant and intravital 
two-photon imaging to study trans-epithelial DC extension 
into the small bowel. Our data confi  rm and extend previous 
reports on the capacity of lamina propria DCs to send pro-
cesses across the columnar epithelial layer without disruption 
of the tight junction between these cells and to interact with 
lumenal microbial fl  ora (13, 17, 19). Most of the DC exten-
sions showed an unusual spherical shape, and their frequency 
diff  ered markedly along the length of the small bowel. In the 
more proximal small bowel segments in which the DC pro-
cesses were numerous in normal uninfected animals, such 
extension appeared to refl  ect an active response to local com-
mensal fl  ora and bacterial products. The vast majority of such 
responses to endogenous bacteria and those occurring in the 
presence of exogenous species such as Salmonella involved 
MyD88-dependent signaling evoked by interaction of any of 
several epithelial TLRs with cognate microbial products.
Two previous studies reported the distribution of small 
bowel trans-epithelial extensions of lamina propria DCs, us-
ing static imaging based on expression of EGFP under the 
control of the CX3CR1 regulatory region (13, 19). In these 
reports, the highest frequency of such extensions was ob-
served in the terminal ileum in mice of the C57BL/6 back-
ground, which were also used here. In marked contrast, we 
found that with a conventional gut fl  ora, substantial numbers 
of such processes are present in the proximal ileum and in the 
jejunum, with a concentration toward the apical region of 
the villi, but that only small numbers of such extensions are 
present in the terminal few centimeters of the ileum (the 
peri-cecal region) of these same mice. We obtained a similar 
result using two diff  erent reporter strains (MHC CII-EGFP 
and CD11c-EGFP). Furthermore, in contrast to what was 
observed by Niess et al. (19) using CX3CR1-EGFP+/+ mice 
that are unresponsive to CX3CL1 (38), we were able to de-
tect the presence in these mutant animals of trans-epithelial 
dendrites, but only in the proximal ileum of Salmonella-
treated mice. At present, we do not have a defi  nitive expla-
nation for the diff  erence between our fi  ndings and the results 
of these two previous studies. However, it may be important 
that our work involved imaging based on EGFP expression 
by what may be a much larger and potentially distinct frac-
tion of DCs, based on control of the reporter by the CD11c 
(21) or MHC class II (20) gene regulatory regions. Given the 
absence of a measurable change in CX3CL1 mRNA expres-
sion in response to bacterial stimuli that potently induce DC 
extensions in the terminal ileum, and the induction of exten-
sions in the proximal bowel of animals lacking CX3CR1 ex-
pression, these fi  ndings suggest that induced up-regulation of 
CX3CL1 does not play a direct role in the DC extension 
process, but that the absence of CX3CR1 may change the 
characteristics of the DCs resident in intestinal epithelium, 
perhaps altering the adhesive properties of these cells (39).
A primary focus of the present work was on control of 
the extension process. Treatment with broad-spectrum anti-
biotics to reduce the load of commensal organisms reduced 
the number of DC extensions seen in the jejunum and proxi-
mal ileum where the number of extensions was high in un-
treated, uninfected animals. This result suggested that active 
responses to microbial products contribute to the DC protru-
sion process, and in accord with this notion, the introduction 
of viable invasive or noninvasive Salmonella organisms in-
duced DC trans-epithelial extensions in the terminal ileum 
(peri-cecal region) where these processes were rare in normal 
animals. One possible explanation for the low frequency of 
extensions in the pre-cecal region of normal mice is a higher 
level of defensin production in this site. This suggestion is in 
accord with the variation in protrusion frequency we ob-
served along the length of an individual villus. It was low 
Figure 6.  Epithelial cell continuity is preserved during DC extension. 
Three sequential images of a villus in an ileal explant from an MHC 
CII-EGFP mouse given Salmonella orally and immersed in buffer containing 
TRITC-dextran showing the exclusion of the tracer from the basolateral 
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near the crypts containing Paneth cells that produce high 
levels of defensins (40) and greater toward the apex where 
the antimicrobial mediators would be less abundant. Pre-
sumably, the high dose of bacteria administered was able to 
overcome local defense mechanisms that may otherwise 
limit the local availability of microbial stimuli able to induce 
DC extensions.
The evidence that DC protrusion could be infl  uenced by 
bacterial load suggested a possible role in this process for sig-
naling through receptors sensitive to microbial products. 
TLRs were the most likely candidates, and various TLRs are 
expressed on the apical surface of gut epithelium (41). In 
agreement with this notion, individual TLR ligands such as 
LPS (TLR4), PG (TLR2), or CpGs (TLR9) induced a sub-
stantial increase in the frequency of such extensions in the 
peri-cecal region, as did Salmonella. The TLR3 ligand poly
(I:C) was not able to induce a change in DC extension fre-
quency. This is consistent with the observation that TLR3 is 
not expressed by the intestinal epithelium. Intriguingly, fl  a-
gellin, whose receptor is TLR5, was also unable to cause this 
response. This fi  nding is in accord with recent studies that 
show a very low level or no expression of TLR5 by the epi-
thelium of the ileum and with the ability of fl  agellin to in-
duce a humoral response only after the disruption of epithelial 
continuity (27, 28, 42). Collectively, these data indicate that 
several but not all lumenal PAMPs can stimulate the intesti-
nal epithelium to induce an extension response from lamina 
propria DCs.
Experiments using radiation chimeras showed that mi-
crobial products required signaling via TLRs expressed by 
nonhematopoietic (epithelial) cells to evoke the DC response, 
that engagement of any of several TLRs was suffi   cient, and 
that the signaling process was largely MyD88 dependent. 
Indeed, in nonchimeric MyD88-defi  cient mice, the number of 
DC extensions seen in the absence of added bacteria or PAMPS 
was reduced almost to zero. We have not yet been able to 
study directly the reciprocal issue of whether TLR signaling 
by the lamina propria DCs is also required for the extension 
process. However, the fact that lamina propria DCs have been 
reported not to express TLR4 (27), our observations that LPS 
alone can induce DC extensions, and the fi  nding that bone 
marrow chimeras with TLR4 expression only on hematopoi-
etic cells do not show DC extension in response to LPS sug-
gest that the TLR signaling by epithelial cells is necessary and 
suffi   cient to induce the extension phenomenon.
The observation of robust MyD88-dependent induction 
of CCL20 transcription in the ilea of animals given nonin-
vasive Salmonella provides further evidence for an active 
  epithelial cell response to TLR engagement. Whether this 
chemokine plays any role in promoting DC extension is an 
open question at the moment. We have not detected an in-
creased number of DCs in the terminal ileum at early times 
after Salmonella administration even though CCL20 has been 
reported to recruit DC precursors to the small bowel (14). 
Therefore, it is unlikely that CCL20 contributes to an acute 
increase in the number of DC extensions by enlarging the 
pool of DCs present in the lamina propria. A possible role for 
CCL20-dependent cell shape changes has not yet been ruled 
in or out by direct experiment.
In agreement with previous in vitro and static imaging 
studies (13, 17, 19), we fi  nd that DC extensions are able to 
interact with intralumenal microbial material. Our live imag-
ing data clearly show the interaction of DC luminal BBs with 
Figure 7.  Interaction of inert particles and bacteria with DC ex-
tensions in the bowel lumen. (A) A time sequence of images from the 
same region of a villus in the terminal ileum of an MHC CII-EGFP mouse. 
The mouse was given noninvasive Salmonella (red) orally. A segment of 
the terminal ileum was isolated 5 h later, the epithelium was stained us-
ing Cell Tracker Blue, and the preparation was imaged by two-photon 
microscopy. A BB can be seen interacting with a fl  uorescent bacterium 
before internalizing it. (B) A three-dimensional section of a villus in the 
terminal ileum from an MHC CII-EGFP mouse. Noninvasive Salmonella 
(red) was given orally 5 h before the terminal ileum was explanted and 
stained with Cell Tracker Blue. A Salmonella bacterium just internalized 
by a DC extension with the typical BB shape is shown by the colocaliza-
tion of green and red in the three-dimensional section (also see Videos 
S6 and S7).JEM VOL. 203, December 25, 2006  2849
ARTICLE
noninvasive labeled Salmonella (36, 37) for several minutes 
and the presence of bacteria in subepithelial DCs. At this 
time, we have no evidence that DC sampling is discrimina-
tory. Both inert beads and either invasive or noninvasive bac-
teria are acquired well by lamina propria DCs based on 
analysis of static images, and both can be seen associating with 
DC extensions in live images (unpublished data). But it 
would be surprising if scavenger receptors, FcR, and C-type 
lectins did not defi  ne the preferred targets of the capture pro-
cess (43). We have not yet been able to follow a DC with an 
internal microbial load leaving its sub-epithelial position and 
entering a lymphatic for migration to a local lymph node 
(44), migrating to a nearby Payer’s patch to initiate a response 
in this site (45–48), or interacting with a memory T cell 
within the lamina propria. New methods for maintaining an-
imal anesthesia for more prolonged periods, together with 
bacteria labeled with nonbleaching probes such as quantum 
dots (49), may allow both the capture process and the subse-
quent fate of the loaded DC to be visualized.
The spherical shape of the DC extensions (BBs) was un-
expected. We cannot at present rule out that this is an artifact 
of the imaging method, perhaps due to removal of the mucus 
layer that typically covers the epithelial cell apical surface and 
that might constrain the shape of the DC protrusion. In a 
buff  er-fi  lled lumen, membranes moving past the end of the 
tight junction and lacking support from F-actin (unpublished 
data) may simply take the energetically most favorable shape, 
that of a sphere.
A characteristic feature of the immune system is the dy-
namic behavior of its constituent cells. The development of 
methods for high resolution intravital imaging of lymphoid 
(50, 51) and other tissue sites (52–55) has begun to reveal 
how immune cells move, interact, and respond in situ, add-
ing to our understanding of normal and pathological immune 
events. Our visualization here of active DC extension into 
the small bowel lumen and the description of the fi  rst steps in 
the signaling cascade controlling this process provide a clear 
example of the utility of this new technology in adding to the 
insights already generated from more conventional analyses 
of this important host–pathogen interface.
MATERIALS AND METHODS
Animals. CD11c-EGFP transgenic mice (21), CX3CR1-EGFP mice (38), 
TLR2-defi  cient mice (31), and TLR4-defi  cient mice (29, 30) were obtained 
from The Jackson Laboratory. MHC CII-EGFP knock-in mice (line 270 on 
a RAG-2−/− background; reference 20) were produced at Taconic Farms 
from breeding stock provided by H. Ploegh (Harvard Medical School, 
  Boston, MA). MyD88-defi  cient mice (32) were provided by S. Akira (Osaka 
University, Osaka, Japan). CX3CR1-EGFP mice on a BALB/c background 
were provided by B. Graham and T. Johnson (Vaccine Research Center, 
NIAID, NIH). All other animals were on the C57BL/6 background, and all 
mice were housed and handled according to NIH institutional guidelines 
under an approved animal protocol.
Intestinal DC purifi  cation. Intestinal tissue from killed line 270 CD11c-
EGFP mice was opened longitudinally and washed several times in PBS. The 
tissue was cut into 1-cm pieces, and these fragments were incubated at 37°C 
on a shaking platform with 145 μg/ml DTT and 0.37 mg/ml EDTA in PBS 
for 15 min. The tissue was then washed several times in 145 μg/ml DTT in 
PBS, and then digested in RPMI 1640 containing 0.15 mg/ml type II colla-
genase (Worthington) and 0.1 mg/ml DNase (Roche Molecular Biochemicals) 
for 60 min at 37°C on a shaking platform. The released cells were enriched 
by 25% Percoll gradient (Sigma-Aldrich), stained with anti–CD11c-APC, 
and analyzed by fl  ow cytometry.
Construction of bone marrow chimeras. 3–5-wk-old TLR4- or 
TLR2-defi  cient recipient mice were sublethally irradiated with 900 rads, 
whereas MyD88-defi  cent recipient mice were irradiated with 500 rads. On 
the same day, 5 × 104 bone marrow cells from CD11c-EGFP or MHC CII-
EGFP mice were harvested and infused into TLR4-defi  cient or into TLR2- 
or MyD88-defi  cient irradiated recipient mice via the tail vein, respectively, 
to create CD11c-EGFP/TLR4−/−, MHC CII-EGFP/TLR2−/−, or MHC 
CII-EGFP/MyD88−/− bone marrow chimeras. These mice were kept in 
isolators and provided neomycin-containing water until use 8–10 wk later.
Reagents. RPMI 1640 medium without phenol red was purchased from 
Biosource International. LPS (Escherichia coli serotype 026:B6) and TRITC-
dextran (160,000 mw) were obtained from Sigma-Aldrich. Poly(I:C) was 
  obtained from GE Healthcare. CpGs (G  C  T  A  G  A  C  G  T  T  A  G  G  T   and T  C  A  A  C-
G  T  T  G  A  ; reference 56) were synthesized at the Facility for Biotechnology Re-
sources at the NIH. Fluorescent beads (Fluorobrite polychromatic red; 1-μm 
microspheres) were obtained from Polysciences, Inc. Anti–mouse CD11c 
mAb labeled with APC was purchased from BD Biosciences.
Bacterial strains and oral administration. Unless otherwise stated, all 
in vivo experiments involved the administration of attenuated Salmonella 
typhimurium defi  cient in both the SP-1 (InvA-) and SP-2 (ssaV) genes, con-
ferring the invasive phenotype and the capacity for intraphagosomal survival, 
respectively (36, 37). In selected experiments, the invasive S. typhimurium 
strain SL1344 (57) was also used. A recombinant red fl  uorescent variant of 
each strain was generated by expressing the red fl  uorescent protein DsRed 
under the transcriptional control of the LacZ promoter. These bacterial 
strains were grown as described previously (58). Preparation and feeding of 
mice with bacteria was performed with 200 μl (10%, wt/vol) NaHCO3 
given 10 min before 200 μl of bacterial suspension (2 × 109 bacteria in PBS) 
or 1 mg/ml LPS or 1 mg/ml PG. Mice were deprived of food for 4 h 
  before and 1 h after oral treatment, which was performed using an animal 
feeding needle.
Antibiotic treatment. For experiments involving the eff  ect of normal gut 
fl  ora on luminal DC projections, we included 5 mg/ml ampicillin, 3 mg/ml 
kanamycin, and 5 mg/ml neomycin in the drinking water for 5 d before analysis.
Real-time quantitative RT-PCR. Ileal samples were collected 2 cm 
above the cecum, the luminal content was carefully washed out, and total 
RNA was extracted using the RNeasy Mini kit Protocol (QIAGEN). cDNA 
was synthesized from  1 μg total RNA using the SuperScript III First-
Strand Synthesis System for RT-PCR (Invitrogen) according to the manu-
facturer’s protocol. Expression levels of CCL20, CX3CL1, and GAPDH 
mRNA were measured by quantitative PCR based on the manufacturer’s 
recommended protocol with the TaqMan Universal PCR Master Mix, fol-
lowed by analysis on an ABI7900 (Applied Biosystems). Triplicate reactions 
were performed for each cDNA preparation. Data were expressed as 2∆∆CT 
relative to GAPDH levels in each sample.
Explant preparation. Mice were deprived of food for 4 h before and, in 
the case of administration of bacteria or LPS, 1 h after these procedures be-
fore being killed by CO2 asphyxiation. The intestine was then removed sur-
gically, and the region of interest was immediately everted and washed twice 
with PBS at 37°C. The epithelium was stained using 20 μM SNARF or 
100 ng/ml Cell Tracker Blue (both from Invitrogen) for 3 min at 37°C in 
PBS. The everted intestinal segment was then immobilized on the surface of 
a Petri dish using Vetbond epoxy glue (3M Animal Care Products) and a 
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phenol red–free RPMI maintained at 37°C within a custom microscope 
  enclosure fi  tted with both an environmental heater and a thermal blanket. 
Experiments conducted with and without the use of medium superfused 
with a gas mixture of 95% O2/5% CO2 gave similar results.
Intravital preparation for microscopy. Mice were anesthetized using 
nebulized isofl  uorane (2% induction, 1% maintenance) in 30% O2/68–69% 
air. The abdomen was shaved, and a vertical incision was performed at the 
cecal level to reveal the terminal ileum. The terminal 7–8 cm of the small 
intestine was externalized from the peritoneum while carefully preserving 
blood fl  ow and lymphatic vessel continuity. The region of interest was then 
immobilized on the disposable stage by using both a solid support and Vet-
bond tissue adhesive. The lumen was surgically exposed using a battery-
  operated cautery (AARON Medical) and washed several times with PBS at 
37°C to remove fecal material and mucus from lumenal surfaces. The epithe-
lial surface was then stained with 200 μl SNARF diluted in 20 μM PBS at 
37°C for 3 min. In some cases nuclei were stained blue using Hoechst 33342. 
After washing with PBS at 37°C, the exposed region of the bowel was 
bathed in phenol red–free RPMI 1640 at 37°C, and the whole animal was 
placed within an enclosed microscope stage fi  tted with both an environmental 
heater and a thermal blanket.
Two-photon microscopy. Two-photon microscopy was conducted 
using a Bio-Rad Laboratories/Carl Zeiss MicroImaging, Inc. Radiance 
2100MP system equipped with a Nikon 600FN upright microscope, 20× 
water immersion lens (N.A. 0.95; Olympus), and either a Mira 900 Sa:Ti 
femtosecond-pulsed laser driven by a 10-W Verdi pump laser (Coherent) 
or a Chameleon laser (Coherent) with similar specifi  cations, both tuned to 
880 nm. The typical pixel size of the image fi  eld was 1.09 μm, and the x-y 
dimensions of the scan area were 560 × 560 μm. The typical optical z-step 
size was 1.5 μm. Serial x-y images were collected over the entire z depth 
every 30–60 s, and the entire process was repeated for up to 120 min to ob-
tain a four-dimensional dataset.
Topographic analysis of BBs. The terminal part of the ileum from MHC 
CII-EGFP mice was surgically removed, immediately everted, and stained 
using 20 μM SNARF-1. Two-photon microscopy at 880 nm using the im-
aging conditions described above was then used to collect high resolution 
static images of complete villi starting from the tips and ending at the bases. 
The number of protrusions (BBs) in an x-y image at a particular z-step and 
the total number of z-step images (ZTot) from the tip to base of the villus 
were recorded. Each villus was arbitrarily subdivided into 10 equal-sized 
compartments from the bottom to the apical region. Relative BB positions 
were then calculated using the following equation: BB = ZBB × 100 / ZTot. 
The numbers of DC extensions per villus were expressed as mean ± SE.
Regional BB distribution. The small intestine was explanted and subdivided 
in six 5-cm segments. Each segment was everted, stained with SNARF, and 
immobilized on a Petri dish as described previously. Two-photon microscopy 
was then used to acquire images of randomly selected areas within these small 
intestine segments. The number of DC extensions was determined by inspec-
tion of each z-slice in image stacks collected at multiple sites within the indi-
cated subregions of the small bowel.
Epithelial cell continuity detection. The explants were prepared as 
described previously. During image acquisition, 200 μl of 10 mg/ml 
TRITC Dextran in PBS was added to the medium in the Petri dish, and 
imaging continued.
Image processing. Datasets were processed using edge-preserving fi  lters 
for the green channel and a median fi  lter for the red and blue channels 
(Bitplane, 4.2; Imaris) to denoise the images. The same software was used to 
color balance the images, with all manipulations of color and intensity ap-
plied equally to an entire image stack, and the resulting fi  les used create two-
dimensional maximum intensity projections for the image stack corresponding 
to each time segment. These projections were then combined using Adobe 
After Eff  ects to generate video sequences. The rate enhancements of these 
videos relative to real time are indicated in the legends.
Statistics. All data were expressed as average values of experimental data 
points, and SEs were determined using the calculated standard deviation of 
a dataset divided by the number of data points within each dataset. p-values 
for the comparison of two data samples were obtained using the two-tailed 
Student’s t test.
Online supplemental material. Fig. S1 shows that MHC class II–EGFP 
cells are CD11c+. Fig. S2 shows the presence of DC extensions in the lumen 
of a CX3CR1+/+ EGFP mouse. Fig. S3 shows CCL20 production by epithe-
lial cells in response to Salmonella. Videos S1 and S2 show reconstructions of 
DC extensions across the epithelial layer of the terminal ileum. Video S3 shows 
diff  erent shapes of the extensions through the epithelium. Video S4 shows 
a dendrite reaching the luminal side and acquiring the BB shape. Video S5 
shows that epithelial cell continuity is preserved during DC extension. Videos S6 
and S7 show DC extensions that capture fl  uorescent Salmonella. The online 
supplemental material is available at http://www.jem.org/cgi/content/full/
jem.20061884/DC1.
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